Works about BILE duct tumors


Results: 890
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study).

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 447, doi. 10.1159/000533669
    By:
    • Kobayashi, Shogo;
    • Wada, Hiroshi;
    • Sakai, Daisuke;
    • Baba, Hideo;
    • Kanai, Masashi;
    • Kamachi, Hirofumi;
    • Takayama, Tadatoshi;
    • Ueno, Masaki;
    • Takahashi, Masahiro;
    • Sho, Masayuki;
    • Yoshimura, Kenichi;
    • Hatano, Etsuro;
    • Nagano, Hiroaki;
    • Ioka, Tatsuya
    Publication type:
    Article
    28

    Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.

    Published in:
    Oncology, 2024, v. 102, n. 2, p. 157, doi. 10.1159/000533406
    By:
    • Vivaldi, Caterina;
    • Genovesi, Virginia;
    • Ugolini, Clara;
    • Bernardini, Laura;
    • Casadei-Gardini, Andrea;
    • Formica, Vincenzo;
    • Salani, Francesca;
    • Orsi, Giulia;
    • Massa, Valentina;
    • Cacciato-Insilla, Andrea;
    • Caccese, Miriam;
    • Cesario, Silvia;
    • Andrikou, Kalliopi;
    • Graziani, Jessica;
    • Campani, Daniela;
    • Vasile, Enrico;
    • Fontanini, Gabriella;
    • Fornaro, Lorenzo;
    • Masi, Gianluca
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

    Published in:
    Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae256
    By:
    • Prinzi, Federica Lo;
    • Salani, Francesca;
    • Rimini, Margherita;
    • Rizzato, Mario Domenico;
    • Antonuzzo, Lorenzo;
    • Camera, Silvia;
    • Satake, Tomoyuki;
    • Vandeputte, Hanne;
    • Vivaldi, Caterina;
    • Pressiani, Tiziana;
    • Lucchetti, Jessica;
    • Kim, Jin Won;
    • Abidoye, Oluseyi;
    • Rapposelli, Ilario Giovanni;
    • Tamberi, Stefano;
    • Finkelmeier, Fabian;
    • Giordano, Guido;
    • Pircher, Chiara;
    • Chon, Hong Jae;
    • Braconi, Chiara
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.

    Published in:
    Oncologist, 2024, v. 29, n. 1, p. e97, doi. 10.1093/oncolo/oyad220
    By:
    • Okano, Naohiro;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Sadachi, Ryo;
    • Kataoka, Tomoko;
    • Kobayashi, Satoshi;
    • Ikeda, Masafumi;
    • Ozaka, Masato;
    • Mizutani, Tomonori;
    • Sugimori, Kazuya;
    • Todaka, Akiko;
    • Shimizu, Satoshi;
    • Mizuno, Nobumasa;
    • Yamamoto, Tomohisa;
    • Sano, Keiji;
    • Tobimatsu, Kazutoshi;
    • Katanuma, Akio;
    • Gotoh, Kunihito;
    • Yamaguchi, Hironori;
    • Ishii, Hiroshi
    Publication type:
    Article
    50

    Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.

    Published in:
    Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
    By:
    • Tella, Sri Harsha;
    • Foster, Nathan;
    • Qian, Shi;
    • Nguyen, Tran;
    • Borad, Mitesh J;
    • McWilliams, Robert R;
    • Alberts, Steven R;
    • Ma, Wen Wee;
    • Chakrabarti, Sakti;
    • Fruth, Briant;
    • Wessling, Jaclynn;
    • Hartgers, Mindy;
    • Washburn, Leslie;
    • Fernandez-Zapico, Martin E;
    • Hogenson, Tara L;
    • Pitot, Henry;
    • Jin, Zhaohui;
    • Mahipal, Amit
    Publication type:
    Article